Literature DB >> 10438386

Molecular evidence of simian virus 40 infections in children.

J S Butel1, A S Arrington, C Wong, J A Lednicky, M J Finegold.   

Abstract

Recent studies have detected simian virus 40 (SV40) DNA in certain human tumors and normal tissues. The significance of human infections by SV40, which was first discovered as a contaminant of poliovirus vaccines used between 1955 and 1963, remains unknown. The occurrence of SV40 infections in unselected hospitalized children was evaluated. Polymerase chain reaction and DNA sequence analyses were done on archival tissue specimens from patients positive for SV40 neutralizing antibody. SV40 DNA was identified in samples from 4 of 20 children (1 Wilms' tumor, 3 transplanted kidney samples). Sequence variation among SV40 regulatory regions ruled out laboratory contamination of specimens. This study shows the presence of SV40 infections in pediatric patients born after 1982.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Substances:

Year:  1999        PMID: 10438386     DOI: 10.1086/314915

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Polyomavirus-associated nephropathy.

Authors:  Cristina Costa; Rossana Cavallo
Journal:  World J Transplant       Date:  2012-12-24

2.  Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort.

Authors:  Valentina Paracchini; Seymour Garte; Paola Pedotti; Francesca Poli; Sara Frison; Emanuela Taioli
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 3.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

5.  High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.

Authors:  Elisa Mazzoni; Alfredo Corallini; Alfonso Cristaudo; Angelo Taronna; Gianfranco Tassi; Marco Manfrini; Manola Comar; Massimo Bovenzi; Roberto Guaschino; Francesca Vaniglia; Corrado Magnani; Ferruccio Casali; Giovanni Rezza; Giuseppe Barbanti-Brodano; Fernanda Martini; Mauro G Tognon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

6.  Polyomavirus shedding in the stool of healthy adults.

Authors:  John A Vanchiere; Suhaib Abudayyeh; Christina M Copeland; Lee B Lu; David Y Graham; Janet S Butel
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

Review 7.  Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation.

Authors:  Kamel Khalili; Ilker Kudret Sariyer; Mahmut Safak
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

8.  Evidence of simian virus 40 exposure in a colony of captive baboons.

Authors:  Landon W Westfall; Michael H Shearer; Cynthia A Jumper; Gary L White; James F Papin; Richard Eberle; Janet S Butel; Robert K Bright; Ronald C Kennedy
Journal:  Virology       Date:  2008-05-16       Impact factor: 3.616

9.  Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters.

Authors:  Vojtech Sroller; Regis A Vilchez; A Renee Stewart; Connie Wong; Janet S Butel
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

10.  Antibodies reacting with Simian virus 40 mimotopes in serum samples from patients with thalassaemia major.

Authors:  Caterina Borgna-Pignatti; Elisa Mazzoni; Marcella Felletti; Giuliana Turlà; Cristina Malaventura; Maria Domenica Cappellini; Paolo Cianciulli; Gian Luca Forni; Alfredo Corallini; Fernanda Martini; Mauro Tognon
Journal:  Blood Transfus       Date:  2014-03-19       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.